Plus Therapeutics, Inc. will hold its Annual Meeting of Stockholders on August 7, 2025. The meeting will be a completely virtual event. During the meeting, stockholders will vote on the election of six board members for a one-year term and the potential issuance and sale of up to $50 million in common stock, as well as up to $1 million in shares as a commitment fee to Lincoln Park Capital Fund, LLC.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Plus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-026611), on July 21, 2025, and is solely responsible for the information contained therein.